E Canada Now Vytorin Study's Ethical Morass Forbes - 2 hours ago Cardiologists and statisticians are arguing about whether the cholesterol drug Vytorin might increase the rate of cancer deaths. But experts on both sides of the argument agree on one thing: They don’t like the way the results were made public. Medical Journal Raises Concern About Vytorin Wall Street Journal Editors warn: Don't 'just brush aside' Vytorin-cancer link USA Today New York Times - Washington Post - dBTechno - WebMD all 464 news articles ...
Anytime
